我国药品低可负担性原因分析  

An Analysis of the Low Affordability of Medicines and Drugs in China

作　　者：阳昊[1] 王迪飞[1] 刘高伍[1] 张新平[1] 

机构地区：[1]华中科技大学同济医学院,武汉430030

出　　处：《医学与社会》2009年第2期22-24,共3页Medicine and Society

摘　　要：我国药品可负担性低主要表现在药品费用高,患者自付比例增长过快。我国药品可负担性低的原因主要有药品价格高、用量多和可替代性等。其中,药品价格高的主要原因是进口药品、合资药品价格高,部分国产"新药"定价虚高等;人口增长,人口老龄化和健康意识提高促进药品使用量上升,医疗保障制度下供需双方的道德风险致使药品使用量增加成为药品费用居高不下主要原因;此外还有药品可替代性的影响。The low affordability of medicines and drugs in China is mainly reflected in their high prices and the fast increasing proportion of expenditure from patients themselves. The major reasons for the low affordability are the high priced imported medicines and drugs, brand medicines and drugs produced by joint-ventures, and overpriced ＂new medicines and drugs＂ produced by domestic pharmaceutical manufacturers. Other reasons such as the increasing population, the aging of the population, the increasing health consciousness among citizens that promotes medication consumption, and the moral risk caused by the current health insurance system which boosts medicine consumption that are all contribumble to the stable high medicine prices in China; Additionally, medicine substitutability is also an influencing factor to high medicine prices.

关 键 词：药品 可负担性 原因 

分 类 号：R956[医药卫生—药学]